➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Colorcon
McKinsey
Moodys
Harvard Business School

Last Updated: March 6, 2021

DrugPatentWatch Database Preview

Litigation Details for Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. (D. Del. 2018)

Docket   Start Trial Date Filed 2018-05-07
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand None Referred To
Parties MSN LABORATORIES PRIVATE LIMITED
Patents 10,071,977; 10,149,829; 9,060,995; 9,539,234; 9,549,913; 9,730,910; 9,855,241; RE46,604
Attorneys Nicholas Groombridge
Firms Phillips, Goldman, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2019-12-03 114 Notice of Service U.S. Patent No. 10,071,977; (2) Defendants' Amended Invalidity Contentions Regarding U.S. Patent No. 10,149,829… 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-12-10 115 Notice of Service Supplemental Infringement Contentions for U.S. Patent No. 10,071,977 to Teva; and (2) Vanda's Supplemental Infringement…Infringement Contentions for U.S. Patent No. 10,071,977 to MSN filed by Vanda Pharmaceuticals Inc..(Fahnestock… 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-12-23 118 Notice of Service Invalidity Contentions Concerning U.S. Patent No. 10,071,977 2) Defendants Second Amended Invalidity …Invalidity Contentions Regarding U.S. Patent No. 10,149,829 3) Defendants Third Amended Invalidity Contentions … 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-01-30 122 Notice of Service . Regarding Infringement by MSN of U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Jacobs… 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-02-03 124 Notice of Service Report of Dr. Robert B. Perni Regarding U.S. Patent No. 10,071,977 (2) First Expert Report of Dr. Jonathan … 7 May 2018 1:18-cv-00690 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Express Scripts
Harvard Business School
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.